Beam Therapeutics, Inc. (BEAM)
26.77
-0.33
(-1.22%)
USD |
NASDAQ |
Dec 09, 14:00
Beam Therapeutics Total Liabilities (Quarterly): 345.08M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 902.34M |
| Intellia Therapeutics, Inc. | 176.85M |
| Regeneron Pharmaceuticals, Inc. | 9.212B |
| Twist Bioscience Corp. | 168.90M |
| Amicus Therapeutics, Inc. | 638.39M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.311B |
| Shareholders Equity (Quarterly) | 966.00M |
| Debt to Equity Ratio | 0.1567 |
| Current Ratio | 6.018 |
| Net Debt Paydown Yield | 0.11% |